000 | 01251cam a2200217 4500 | ||
---|---|---|---|
001 | 4431550305 | ||
008 | 161207t2016 xxu||||| |||| 00| 0 eng d | ||
020 | _a4431550305 | ||
020 | _a9784431550303 | ||
100 | _aYamaguchi, Yoshiyuki (ed) | ||
245 | 0 | _aImmunotherapy of cancer | |
260 |
_aTokyo : _bSpringer, _c2016 |
||
505 | _aOverview, history, classification; BRMs and crude agents; Adoptive cell therapy; Vaccine therapy; Immunoadjuvants; Immunocheckpoints; Regulation of immunosuppression; Immune-related response criteria and guidance for clinical trials; Personalized immunotherapy | ||
520 | _aThis timely book, published just as cancer immunotherapy comes of age, summarizes the rationale, present status, and future perspective for cancer immunotherapy. Included are explanations of the constitution of the immune system and immunocheckpoints, the mechanism of antigen presentation and recognition, valuable modalities, clinical trials and guidance, personalization, and biomarkers, all of which are essential for understanding the success of cancer immunotherapy | ||
650 | _aCancer | ||
650 | _aCancer - Immunotherapy | ||
650 | _aImmunology | ||
690 | _aImmunology | ||
690 |
_aImmunotherapy _96577 |
||
690 | _aCancer | ||
999 |
_c40233 _d40233 |